Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
COO Stock Forecast 2025-2026
$72.13
Current Price
$14.34B
Market Cap
Buy 11
Hold 7
Sell 1
Wall St Analyst Ratings
Distance to COO Price Targets
+33.1%
To High Target of $96.00
+17.8%
To Median Target of $85.00
-11.3%
To Low Target of $64.00
COO Price Momentum
+2.9%
1 Week Change
+4.9%
1 Month Change
-27.6%
1 Year Change
-21.5%
Year-to-Date Change
-32.4%
From 52W High of $106.63
+16.8%
From 52W Low of $61.78
📊 TOP ANALYST CALLS
Did COO Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cooper Companies is one of their latest high-conviction picks.
Latest COO Stock Price Targets & Analyst Predictions
Based on our analysis of 24 Wall Street analysts, COO has a bullish consensus with a median price target of $85.00 (ranging from $64.00 to $96.00). The overall analyst rating is Buy (7.6/10). Currently trading at $72.13, the median forecast implies a 17.8% upside. This outlook is supported by 11 Buy, 7 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by David Roman at Goldman Sachs, suggesting a 11.3% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
COO Analyst Ratings
11
Buy
7
Hold
1
Sell
COO Price Target Range
Low
$64.00
Average
$85.00
High
$96.00
Current: $72.13
Latest COO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for COO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 13, 2025 | Wells Fargo | Larry Biegelsen | Equal-Weight | Downgrade | $72.00 |
| Oct 13, 2025 | Barclays | Matt Miksic | Overweight | Initiates | $85.00 |
| Oct 1, 2025 | Goldman Sachs | David Roman | Sell | Initiates | $64.00 |
| Aug 28, 2025 | Baird | Jeff Johnson | Outperform | Maintains | $85.00 |
| Aug 28, 2025 | Piper Sandler | Jason Bednar | Overweight | Maintains | $83.00 |
| Aug 28, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $72.00 |
| Aug 28, 2025 | Stifel | Jonathan Block | Buy | Maintains | $85.00 |
| Aug 28, 2025 | Citigroup | Joanne Wuensch | Neutral | Downgrade | $72.00 |
| Aug 28, 2025 | Morgan Stanley | Patrick Wood | Equal-Weight | Maintains | $76.00 |
| Aug 28, 2025 | JP Morgan | Robbie Marcus | Neutral | Maintains | $66.00 |
| Aug 28, 2025 | Needham | David Saxon | Buy | Reiterates | $94.00 |
| Jul 16, 2025 | Mizuho | Anthony Petrone | Outperform | Maintains | $90.00 |
| Jun 17, 2025 | Needham | David Saxon | Buy | Upgrade | $94.00 |
| May 30, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $93.00 |
| May 30, 2025 | Needham | Hold | Reiterates | $N/A | |
| May 30, 2025 | JP Morgan | Robbie Marcus | Neutral | Downgrade | $76.00 |
| May 30, 2025 | Baird | Jeff Johnson | Outperform | Maintains | $97.00 |
| May 30, 2025 | Piper Sandler | Jason Bednar | Overweight | Reiterates | $105.00 |
| May 22, 2025 | Needham | David Saxon | Hold | Reiterates | $N/A |
| Mar 7, 2025 | Stifel | Jonathan Block | Buy | Maintains | $105.00 |
The Cooper Companies, Inc. (COO) Competitors
The following stocks are similar to Cooper Companies based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
COO
Cooper Companies
mkt cap
13.94B
The Cooper Companies, Inc. (COO) Financial Data
The Cooper Companies, Inc. has a market capitalization of $14.34B with a P/E ratio of 35.2x. The company generates $4.05B in trailing twelve-month revenue with a 10.1% profit margin.
Revenue growth is +5.7% quarter-over-quarter, while maintaining an operating margin of +16.6% and return on equity of +5.0%.
Valuation Metrics
Market Cap
$14.34B
Enterprise Value
$16.62B
P/E Ratio
35.2x
PEG Ratio
-5.9x
Price/Sales
3.5x
Growth & Margins
Revenue Growth (YoY)
+5.7%
Gross Margin
+65.3%
Operating Margin
+16.6%
Net Margin
+10.1%
EPS Growth
-6.1%
Financial Health
Cash/Price Ratio
+0.9%
Current Ratio
2.1x
Debt/Equity
29.7x
ROE
+5.0%
ROA
+3.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
The Cooper Companies, Inc. (COO) Business Model
About The Cooper Companies, Inc.
What They Do
Produces medical devices for eye care and women's health.
Business Model
The Cooper Companies generates revenue through its two main business units, CooperVision and CooperSurgical. CooperVision primarily focuses on manufacturing and selling a variety of soft contact lenses tailored to different vision correction requirements, while CooperSurgical offers products and services that address women's health issues, including fertility and surgical tools. This diversified approach ensures multiple revenue streams within the healthcare sector.
Additional Information
Headquartered in San Ramon, California, the company is recognized for its commitment to advancing optical technologies and essential medical devices, positioning itself as a significant player in the global healthcare market.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
16,000
CEO
Mr. Albert G. White III
Country
United States
IPO Year
1983
Website
www.coopercos.comThe Cooper Companies, Inc. (COO) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates
Aytu BioPharma (AYTU) delivered earnings and revenue surprises of -33.33% and +10.05%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 13, 2025
By Zacks Equity Research
Tale of the Tape
Conmed (CNMD) Tops Q3 Earnings and Revenue Estimates
Conmed (CNMD) delivered earnings and revenue surprises of +2.86% and +0.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 05, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
CooperCompanies (Nasdaq: COO) will report its Q4 and full year 2025 financial results on December 4, 2025, at 4:15 PM ET, followed by a conference call at 5:00 PM ET.
Why It Matters
The upcoming financial results and conference call for CooperCompanies may influence stock performance, investor sentiment, and expectations regarding future growth and profitability.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Four dental supplies stocks—MCK, CAH, WST, and COO—are highlighted as potential wealth generators for investors amid ongoing tariff uncertainty.
Why It Matters
The mention of MCK, CAH, WST, and COO suggests potential resilience and growth in the Dental Supplies sector, making them attractive options during tariff volatility.
Source: Zacks Investment Research
Market Sentiment:
Negative
Activist investor Jana Partners takes stake in medical device maker Cooper Companies, WSJ says
26 days ago
Quick Summary
A hedge fund is urging Cooper to enhance its capital allocation strategies to increase returns, according to the Wall Street Journal.
Why It Matters
A hedge fund's pressure on Cooper to enhance capital allocation signals potential changes in strategy, which could affect profitability and stock performance, impacting investor sentiment.
Source: CNBC
Market Sentiment:
Positive
Quick Summary
Cooper Companies (COO) shares rose as activist investor Jana Partners seeks a merger with Bausch + Lomb (BLCO) and other strategic options, amid a 30% year-over-year stock decline.
Why It Matters
The rally in Cooper Companies' shares indicates potential value creation from activist investor involvement, suggesting a possible merger or strategic shift that could enhance shareholder value.
Source: Schwab Network
Market Sentiment:
Positive
Quick Summary
Cooper Companies may outperform the S&P 500, trading at decade-low valuations with insider buying, strong momentum, and a robust balance sheet. They lead in contact lenses and expanded their buyback by $1B.
Why It Matters
Cooper Companies shows potential for strong performance versus the S&P 500, driven by low valuations, insider confidence, resilience in downturns, and a robust share repurchase program.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Bausch + Lomb's CEO expressed interest in acquiring a contact-lens unit, indicating potential expansion in that market segment.
Why It Matters
Bausch + Lomb's interest in acquiring the contact-lens unit could signal strategic expansion, impacting market positioning and future revenue opportunities, influencing investor sentiment positively.
Source: WSJ
Market Sentiment:
Positive
Frequently Asked Questions About COO Stock
What is The Cooper Companies, Inc.'s (COO) stock forecast for 2026?
Based on our analysis of 24 Wall Street analysts, The Cooper Companies, Inc. (COO) has a median price target of $85.00. The highest price target is $96.00 and the lowest is $64.00.
Is COO stock a good investment in 2026?
According to current analyst ratings, COO has 11 Buy ratings, 7 Hold ratings, and 1 Sell ratings. The stock is currently trading at $72.13. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for COO stock?
Wall Street analysts predict COO stock could reach $85.00 in the next 12 months. This represents a 17.8% increase from the current price of $72.13. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is The Cooper Companies, Inc.'s business model?
The Cooper Companies generates revenue through its two main business units, CooperVision and CooperSurgical. CooperVision primarily focuses on manufacturing and selling a variety of soft contact lenses tailored to different vision correction requirements, while CooperSurgical offers products and services that address women's health issues, including fertility and surgical tools. This diversified approach ensures multiple revenue streams within the healthcare sector.
What is the highest forecasted price for COO The Cooper Companies, Inc.?
Price targets from Wall Street analysts for COO are not currently available. The stock is trading at $72.13.
What is the lowest forecasted price for COO The Cooper Companies, Inc.?
The lowest price target for COO is $64.00 from David Roman at Goldman Sachs, which represents a -11.3% decrease from the current price of $72.13.
What is the overall COO consensus from analysts for The Cooper Companies, Inc.?
The overall analyst consensus for COO is bullish. Out of 24 Wall Street analysts, 11 rate it as Buy, 7 as Hold, and 1 as Sell, with a median price target of $85.00.
How accurate are COO stock price projections?
Stock price projections, including those for The Cooper Companies, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 15, 2025 9:55 AM UTC